|Daily Range||$52.02 - $53.21|
|52-Week Range||$33.20 - $54.78|
|Dividend (Yield)||$1.60 (2.9%)|
Dividend Pay Date
|Average Daily Volume||6,042,004|
|Current FY EPS||$3.14|
AbbVie Inc. (ABBV) Description
AbbVie Inc. Website: http://www.abbvie.com/
News & Commentary
Enanta shares sink after a rival hepatitis-C drugmaker delivers phenomenal late-stage results. Is now the time to buy Enanta or flee?
Gilead Sciencs releases data that appears to show its drugs work better than AbbVie's drug combo, although both drugs work better than first-generation drugs from Vertex Pharmaceuticals and Merck.
From great clinical results to a big buyout, Enanta, Given Imaging, and Corcept Therapeutics had humongous weeks.